David Vlahov, RN, PhD, FAAN

Headshot of David Vlahov
User Profile Photo

David Vlahov, RN, PhD, FAAN

User Profile Name
Dean, UCSF School of Nursing
Professor Emeritus, School of Nursing
User Profile Title
User Profile Email

Biography

Dr. Vlahov is Professor Emeritus at the University of California, San Francisco School of Nursing after serving five years as Dean. He served on the faculty as Professor of Epidemiology at the Johns Hopkins and Columbia Universities, and was Adjunct Professor in Medical Schools at Cornell, Mount Sinai and New York University and the College of Nursing at New York University. He has also served as co-Director of the National Program Office(NPO) for the Robert Wood Johnson Foundation Health and Society Scholars program and currently, the NPO for the Foundation's Evidence for Action program. He brings research expertise in urban health, epidemiology, infectious diseases, substance abuse and mental health. Dr. Vlahov conducted studies of urban populations in Baltimore for over 20 years including several longitudinal cohort studies for which he received the NIH MERIT Award. More recently, Dr. Vlahov led epidemiologic studies in Harlem and the Bronx, which have served as a platform for subsequent individual- and community-level intervention studies and community based participatory research (involving partnerships with residents, community based organizations, academic/ public health departments) to address social determinants of health. This work has contributed information on racial/ethnic disparities in health and approaches to address such disparities. Uniting these interests, Dr. Vlahov became Director of the Center for Urban Epidemiologic Studies at the New York Academy of Medicine He was a Visiting Professor at the Medical School in Belo Horizonte, Brazil to develop their programs in urban health, and has been an expert consultant to the WHO’s Urban Health Center in Kobe, Japan. He served on the New York City Board of Health during the Bloomberg administration. Dr. Vlahov is the editor-in-chief of the Journal of Urban Health, has edited three books on urban health and published over 650 scholarly papers. With colleagues he initiated the International Society for Urban Health (www.isuh.org), serving as its first President. He is a member of the National Academy of Medicine (formerly theInstitute of Medicine) and a Fellow of the American Academy of Nursing. He has served on the Board of Directors for the American Association of Colleges of Nursing and as a member on the National Advisory Council for Nursing Education and Practice at HRSA.
CTSI Profile Bio

Displaying 226 - 250 of 679

  1. Pouget ER, Deren S, Fuller CM, Blaney S, McMahon JM, Kang SY, Tortu S, Andia JF, Des Jarlais DC, Vlahov D. Receptive syringe sharing among injection drug users in Harlem and the Bronx during the New York State Expanded Syringe Access Demonstration Program. . 2005 Aug 01; 39(4):471-7.
  2. Kapadia F, Cook JA, Cohen MH, Sohler N, Kovacs A, Greenblatt RM, Choudhary I, Vlahov D. The relationship between non-injection drug use behaviors on progression to AIDS and death in a cohort of HIV seropositive women in the era of highly active antiretroviral therapy use. Addiction. 2005 Jul; 100(7):990-1002.
  3. Wang C, Vlahov D, Galai N, Cole SR, Bareta J, Pollini R, Mehta SH, Nelson KE, Galea S. The effect of HIV infection on overdose mortality. AIDS. 2005 Jun 10; 19(9):935-42.
  4. Vlahov D, Galai N, Safaeian M, Galea S, Kirk GD, Lucas GM, Sterling TR. Effectiveness of highly active antiretroviral therapy among injection drug users with late-stage human immunodeficiency virus infection. Am J Epidemiol. 2005 Jun 01; 161(11):999-1012.
  5. Mitchell CS, Gershon RR, Lears MK, Vlahov D, Felknor S, Lubelczyk RA, Sherman MF, Comstock GW. Risk of tuberculosis in correctional healthcare workers. J Occup Environ Med. 2005 Jun; 47(6):580-6.
  6. Hembree C, Galea S, Ahern J, Tracy M, Markham Piper T, Miller J, Vlahov D, Tardiff KJ. The urban built environment and overdose mortality in New York City neighborhoods. Health Place. 2005 Jun; 11(2):147-56.
  7. Vlahov D, Galea S, Gibble E, Freudenberg N. Perspectives on urban conditions and population health. Cad Saude Publica. 2005 May-Jun; 21(3):949-57.
  8. Vlahov D, Galea S, Freudenberg N. Toward an urban health advantage. J Public Health Manag Pract. 2005 May-Jun; 11(3):256-8.
  9. Howe CJ, Fuller CM, Ompad DC, Galea S, Koblin B, Thomas D, Vlahov D. Association of sex, hygiene and drug equipment sharing with hepatitis C virus infection among non-injecting drug users in New York City. Drug Alcohol Depend. 2005 Sep 01; 79(3):389-95.
  10. Duggal P, Winkler CA, An P, Yu XF, Farzadegan H, O'Brien SJ, Beaty TH, Vlahov D. The effect of RANTES chemokine genetic variants on early HIV-1 plasma RNA among African American injection drug users. . 2005 Apr 15; 38(5):584-9.
  11. Ompad DC, Ikeda RM, Shah N, Fuller CM, Bailey S, Morse E, Kerndt P, Maslow C, Wu Y, Vlahov D, Garfein R, Strathdee SA. Childhood sexual abuse and age at initiation of injection drug use. Am J Public Health. 2005 Apr; 95(4):703-9.
  12. Fuller CM, Borrell LN, Latkin CA, Galea S, Ompad DC, Strathdee SA, Vlahov D. Effects of race, neighborhood, and social network on age at initiation of injection drug use. Am J Public Health. 2005 Apr; 95(4):689-95.
  13. Lai S, Lima JA, Lai H, Vlahov D, Celentano D, Tong W, Bartlett JG, Margolick J, Fishman EK. Human immunodeficiency virus 1 infection, cocaine, and coronary calcification. Arch Intern Med. 2005 Mar 28; 165(6):690-5.
  14. Cox AL, Netski DM, Mosbruger T, Sherman SG, Strathdee S, Ompad D, Vlahov D, Chien D, Shyamala V, Ray SC, Thomas DL. Prospective evaluation of community-acquired acute-phase hepatitis C virus infection. Clin Infect Dis. 2005 Apr 01; 40(7):951-8.
  15. Galea S, Freudenberg N, Vlahov D. Cities and population health. Soc Sci Med. 2005 Mar; 60(5):1017-33.
  16. Tardiff AK, Wallace Z, Tracy M, Piper TM, Vlahov D, Galea S. Drug and alcohol use as determinants of New York City homicide trends from 1990 to 1998. J Forensic Sci. 2005 Mar; 50(2):470-4.
  17. Galea S, Rudenstine S, Vlahov D. Drug use, misuse, and the urban environment. Drug Alcohol Rev. 2005 Mar; 24(2):127-36.
  18. Fuller CM, Absalon J, Ompad DC, Nash D, Koblin B, Blaney S, Galea S, Vlahov D. A comparison of HIV seropositive and seronegative young adult heroin- and cocaine-using men who have sex with men in New York City, 2000-2003. J Urban Health. 2005 Mar; 82(1 Suppl 1):i51-61.
  19. Lambert E, Normand J, Stall R, Aral S, Vlahov D. Introduction: new dynamics of HIV risk among drug-using men who have sex with men. J Urban Health. 2005 Mar; 82(1 Suppl 1):i1-8.
  20. Vlahov D, Galea S, Freudenberg N. The urban health "advantage". J Urban Health. 2005 Mar; 82(1):1-4.
  21. Tracy M, Piper TM, Ompad D, Bucciarelli A, Coffin PO, Vlahov D, Galea S. Circumstances of witnessed drug overdose in New York City: implications for intervention. Drug Alcohol Depend. 2005 Aug 01; 79(2):181-90.
  22. Sterling TR, Pisell-Noland T, Perez JL, Astemborski J, McGriff JR, Nutting L, Hoover DR, Vlahov D, Bollinger RC. Sex-based differences in T lymphocyte responses in HIV-1-seropositive individuals. J Infect Dis. 2005 Mar 15; 191(6):881-5.
  23. Freudenberg N, Galea S, Vlahov D. Beyond urban penalty and urban sprawl: back to living conditions as the focus of urban health. J Community Health. 2005 Feb; 30(1):1-11.
  24. Orloff MS, Iyengar SK, Winkler CA, Goddard KA, Dart RA, Ahuja TS, Mokrzycki M, Briggs WA, Korbet SM, Kimmel PL, Simon EE, Trachtman H, Vlahov D, Michel DM, Berns JS, Smith MC, Schelling JR, Sedor JR, Kopp JB. Variants in the Wilms' tumor gene are associated with focal segmental glomerulosclerosis in the African American population. Physiol Genomics. 2005 Apr 14; 21(2):212-21.
  25. Smit E, Semba RD, Pilibosian E, Vlahov D, Tun W, Purvis L, Tang AM. Body habitus in a cohort of HIV-seropositive and HIV-seronegative injection drug users. AIDS Patient Care STDS. 2005 Jan; 19(1):19-30.